Cargando…
Denosumab as the Treatment of Recalcitrant Tuberculous Pleural Effusion-Associated Hypercalcemia
Denosumab is a human monoclonal antibody that binds to RANKL (receptor activator of nuclear factor-kappa B ligand). It has mainly been used in the treatment of osteoporosis for a variety of causes especially in situations refractory to bisphosphonates or when kidney function is impaired. It is also...
Autores principales: | Abd Jalil, Afdhal Afiq, Wan Muhamad Hatta, Sharifah Faradila, Mohamad, Aimi Fadilah, Abdul Rani, Mohammed Fauzi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079213/ https://www.ncbi.nlm.nih.gov/pubmed/33986809 http://dx.doi.org/10.1155/2021/5544848 |
Ejemplares similares
-
Denosumab-induced hypocalcemia post bariatric surgery—a severe and protracted course: a case report
por: Awang, Mohd Hazriq, et al.
Publicado: (2023) -
Tuberculous Pleural Effusion
por: Schlesinger, Shira A., et al.
Publicado: (2012) -
A case report on a protracted course of a hidden insulinoma
por: Mohamed Shah, Fatimah Zaherah, et al.
Publicado: (2021) -
Sputum AFB in tuberculous pleural effusion
por: Wiwanitkit, Viroj
Publicado: (2011) -
A rare case of macroprolactinoma in a patient with Mayer–Rokitansky–Kuster–Hauser (MRKH) syndrome
por: Zainordin, Nur Aisyah, et al.
Publicado: (2021)